December 11, 2024 - 11:52

In recent years, the international community has repeatedly placed its faith in authoritarian leaders, hoping for a partnership that could lead to reform and stability. Figures like Bashar al-Assad of Syria, Vladimir Putin of Russia, and Muammar Gaddafi of Libya have all been viewed at different times as potential allies by Western powers, despite their notorious records of human rights abuses and aggressive policies.
This phenomenon, often referred to as the "guy we can do business with" myth, reflects a troubling tendency to overlook the darker aspects of these regimes in favor of perceived strategic benefits. The allure of engaging with these leaders often stems from a desire for stability or economic gain, leading to misplaced optimism about their willingness to cooperate on global issues.
However, history has shown that such hopes are frequently dashed. Instead of fostering positive change, these engagements often enable further repression and conflict. As the world grapples with the consequences of these misguided alliances, it becomes clear that the free world must reassess its approach to dealing with despotic regimes. The pattern of seeking out "acceptable" dictators in pursuit of short-term goals must be critically examined to prevent repeating the same mistakes in the future.
May 16, 2026 - 00:10
Blake's Snow Shack owned by man with Down syndrome in Texas turns 10In the small North Texas town of Sanger, a beloved local business is marking a sweet anniversary. Blake`s Snow Shack, a shaved ice stand owned and operated by a man with Down syndrome, is turning...
May 15, 2026 - 04:31
SBA Launches Small Business Pitch Competition » CBIAThe U.S. Small Business Administration has announced a new pitch competition aimed at companies that show strong innovation and have a track record of using SBA-backed financing tools. The contest...
May 14, 2026 - 01:02
INOVIO Reports First Quarter 2026 Financial Results and Recent Business HighlightsINOVIO has released its financial results for the first quarter of 2026, alongside a summary of recent business developments. The company`s primary focus remains on the regulatory path for its lead...
May 13, 2026 - 04:15
Curis Provides First Quarter 2026 Business UpdateCuris, Inc., a biotechnology company advancing the development of its lead drug candidate emavusertib, provided a business update for the first quarter of 2026. The company is focused on...